SBIR/STTR Research Award
CANNABIS IMPAIRMENT DETECTION APPLICATION (CIDA) (T163). SBIR PHASE II. POP: 9/20/2019-9/19/2021. N44DA-19-1218.
Award amount
$1,499,722Program and phase
SBIR · Phase IIAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ADVANCED BRAIN MONITORING, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- CDQ7RHKMN5G7
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
Under this Small Business Innovation ResearchSBIRPhase I projectResearch Topicthe Contractor will develop a portableeasily applied system incorporating a neuropsychological test protocol to detect cannabis impairment
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Characterizing neurocognitive deficits in post-acute sequelae of COVID-19
- Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)
- Neurophysiological Assessment of Information Environment Through a Multi-Sensor Platform
- Cannabis Impairment Detection Application (CIDA)
- Interactive Companion Robot for Preventing Neuro-Cognitive Decline in Alzheimer's and Other Dementias
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
38 SBIR/STTR records share this UEI (1999–2025). Reported award amounts total $19,838,071. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense, Department of Homeland Security